---
title: "Repatha (evolocumab), all indications: Dosing and administration questions"
description: "Dosing and administration questions on Repatha (evolocumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Dosing, Administration, and Taking treatment. Questions: What should patients do if they miss a Repatha dose? How is the Repatha 420 mg monthly dose given? Where and how is Repatha injected? How long does a Repatha injection take? 2 further questions follow. 6 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/repatha/dosing-and-administration"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Repatha (evolocumab), all indications: Dosing and administration questions

Manufacturer: Amgen Inc.  
Prescribing information: [Repatha](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf)  
Indication pages: [Cardiovascular event risk reduction](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction)

## Dosing

<a id="repatha-missed-dose"></a>

### What should patients do if they miss a Repatha dose?

> “If a dose is missed: 
> • 
> Within 7 days from the missed dose, instruct the patient to administer REPATHA and resume the 
> patient’s original schedule.”

Source: [REPATHA: Prescribing information, page 2, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=2)

> “More than 7 days after the missed dose: 
> • 
> For an every 2-week dose, instruct the patient to wait until the next dose on the original 
> schedule. 
> • 
> For a once-monthly dose, instruct the patient to administer the dose and start a new 
> schedule based on this date.”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

## Administration

<a id="repatha-420-mg-dose"></a>

### How is the Repatha 420 mg monthly dose given?

> “The 420 mg dose of REPATHA can be administered: 
> • 
> by giving 3 injections consecutively within 30 minutes using the prefilled single-dose 
> pen, prefilled single-dose SureClick<sup>®</sup> autoinjector, or prefilled single-dose syringe.”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

Note: The Prescribing Information revised 10/2026 lists the prefilled single-dose syringe; the Repatha HCP site, as captured on November 13, 2026, states that the prefilled syringe was to be discontinued by Q1 2026 (see the question on the prefilled syringe).

<a id="repatha-how-to-inject"></a>

### Where and how is Repatha injected?

> “Train patients and/or caregivers on how to prepare and administer REPATHA, according to the 
> Instructions for Use and instruct them to read and follow the Instructions for Use each time they 
> use REPATHA.”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

> “Prior to use, allow REPATHA to warm to room temperature for at least 30 minutes for the 
> prefilled single-dose pen, prefilled single-dose SureClick<sup>®</sup> autoinjector, or prefilled single-dose 
> syringe if REPATHA has been refrigerated [see How Supplied/Storage and Handling (16)]. 
> • 
> Visually inspect REPATHA prior to administration. REPATHA is a clear to opalescent, colorless 
> to pale yellow solution. Do not use if the solution is cloudy, discolored, or contains particles.”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

> “Administer REPATHA subcutaneously into areas of the abdomen, thigh, or upper arm 
> that are not tender, bruised, red, or indurated. Avoid injecting into areas with scars or 
> stretch marks. Rotate injection sites for each administration.”

Source: [REPATHA: Prescribing information, page 3, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=3)

<a id="repatha-injection-time"></a>

### How long does a Repatha injection take?

> “Provide guidance to patients and caregivers on proper subcutaneous administration technique and how to 
> use the prescribed REPATHA device correctly. Inform patients that it may take up to 15 seconds to 
> administer REPATHA using the prefilled single-dose pen, prefilled single-dose SureClick<sup>®</sup> autoinjector, 
> or prefilled single-dose syringe.”

Source: [REPATHA: Prescribing information, page 27, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=27)

<a id="repatha-home-injection"></a>

### Can patients inject Repatha at home with the SureClick autoinjector?

> “94%
> of patients
>
> successfully administer at home with the Repatha<sup>®</sup> SureClick<sup>®</sup> device.<sup>2,†</sup>”

Source: [REPATHA: Dosing and Administration, captured 2026-11-13](https://www.repathahcp.com/dosing-and-administration#:~:text=94%25,administer%20at%20home%20with%20the)

> “<sup>†</sup>Patients who reported 2 full-dose administrations of Repatha<sup>®</sup> at weeks 2 and 4 in THOMAS-1 and weeks 4 and 8 in THOMAS-2. Patients received training from healthcare professionals on how to self-administer.”

Source: [REPATHA: Dosing and Administration, captured 2026-11-13](https://www.repathahcp.com/dosing-and-administration#:~:text=who%20reported%202%20full%2Ddose%20administrations,professionals%20on%20how%20to%20self%2Dadminister.)

Note: The figure is from the THOMAS-1 and THOMAS-2 studies that the dosing page cites (Dent R, et al. SpringerPlus. 2016); the page reports no comparison group.

## Taking treatment

<a id="repatha-stopping"></a>

### What happens if a patient stops taking Repatha?

> “Do not stop using REPATHA without talking with your healthcare provider. If you or your child stop using REPATHA, 
> the cholesterol levels can increase.”

Source: [REPATHA: Prescribing information, page 29, captured 2026-11-13](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf#page=29)

Note: This passage is from the FDA-approved Patient Information printed with the Prescribing Information, which covers adult and pediatric use.

## Related pages
- [Medical information: Repatha (evolocumab): All indications](https://www.evicenter.com/medical-information/repatha)
- [Indication](https://www.evicenter.com/medical-information/repatha/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/repatha/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/repatha/safety)
- [Specific populations](https://www.evicenter.com/medical-information/repatha/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/repatha/drug-interactions)
- [Storage and supply](https://www.evicenter.com/medical-information/repatha/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/repatha/access-and-coverage)
